COVID-19 candidate vaccine induces strong immune response; late-stage trial to start July 23
Wednesday, July 15, 2020 - 03:30
in Health & Medicine
U.S. biotech company Moderna said a vaccine it is developing has shown to induce a "rapid and strong" immune response against COVID-19, stating it will begin late-stage testing in less than two weeks.